Dr. Amogh Karnik, MD

Dr. Karnik practices at Northwestern Medicine Palos Hospital in Palos Heights, Illinois, part of Northwestern Memorial HealthCare.

Dr. Karnik's NPI, 1326579871, was assigned on March 27, 2017. Dr. Karnik holds Illinois license 036.156722.

Dr. Karnik's primary practice is Northwestern Medicine Palos Hospital, at 12251 South 80th Avenue, Palos Heights, IL 60463 in Cook County. The practice phone is (708) 923-4000.

Dr. Karnik's primary practice is Northwestern Medicine Palos Hospital in Palos Heights, Illinois, part of Northwestern Memorial HealthCare. Dr. Karnik is also affiliated with Northwestern Medicine Central DuPage Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Karnik to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karnik practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Karnik's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Karnik's licenses on file in 2 states: Illinois and New Hampshire.

CMS data shows 177 Medicare services from Dr. Karnik across 5 procedure codes in 2024, for 189 Medicare patients. Medicare paid $22,661 for them.

CMS counts 189 Medicare patients who saw Dr. Karnik in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Karnik's median patient age at 72, with 52% women.

In 2024, Dr. Karnik wrote 114 Medicare Part D claims for 61 patients. 85% of them were for generic drugs. CMS names the drug for 43 of them, across 3 drugs with 11 or more claims each, at $21,511 in total drug cost. In 2023, CMS named 50 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Karnik for performance year 2024, reported through an alternative payment model (APM). Dr. Karnik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Karnik as offering telehealth.

CMS Open Payments shows 25 general payments to Dr. Karnik from 3 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $566.